Around ½ of our Colorado Bioscience companies are Medical Device companies. Medical Device companies are favorably viewed by investors, even in today’s economy. Shorter, more predictable R&D cycle times.
More predictable therapeutic outcomes. Typically shorter, more predictable regulatory approval. Margins – depends on the device.
Can be 80% GM for high risk, life-support implantable devices (like heart valves). Also discussed: A New Paradigm for the Treatment of Heart Valve Disease.